Back to catalogue
IDHC
Integrated Diagnostics Holdings PLC
460/1000 Overall fit
AI beneficiary 35% 30
Operating leverage 25% 78
Valuation 25% 30
Downside protection 15% 60
First-pass take
Leading Middle East/Africa diagnostics provider with strong operating leverage: EBITDA margins expanded 29.7%→34.9% YoY, adjusted net profit up 79% on 37% revenue growth. However, 84.6% Egypt concentration with explicit currency volatility headwinds, geopolitical risk (Iran conflict), and zero AI revenue narrative disqualify from AI-focused strategy.
Flags
no-ai-angleno-valuation-datahigh-egypt-exposuregeopolitical-riskcurrency-exposuredefensive